Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report.
Streetwise Reports | May 14, 2020 |

Buzz on the Bullboards: Who Has Emerged from COVID the Strongest?

(Image via Ivanhoe Mines Ltd.) Are we about to see the global economy fully open up and recover, or are we headed for more trouble with new lockdowns and virus variants? The COVID-19 pandemic has played havoc with global stocks for more than a year, but since it...
Stockhouse Editorial | April 7, 2021 |

Hemostemix Founder: A Man with a Compassionate Heart

The Canadian stem cell company Hemostemix Inc. ( TSX-V: HEM , OTC: HMTXF ) was founded by a man who truly had a compassionate heart and a clear intent to establish a breakthrough in heart disease using the same technology that saved his life. Roger Bergersen, who train...
Featured Submission | December 14, 2020 |

Biotech to Test Stem Cell Product in COVID-19-Caused Acute Respiratory Distress

A description of Mesoblast's multi-site clinical trial and possible implication for the therapeutic are provided in an H.C. Wainwright & Co. report. In an April 9 research note, H.C. Wainwright & Co. analyst Swayampakula Ramakanth reported that Mesoblast Lt...
Streetwise Reports | April 16, 2020 |

Buzz on the Bullboards: what does the new year have in store for Canadian stocks?

The Canadian stock market had a good start to 2023. Financial and technology sectors opened strong, driving Canada’s main stock index higher. Energy stocks, however, weakened as the price of oil fell. Oil prices fell nearly 5 per cent yesterday after s...
Shoran Devi | January 5, 2023 |

Buzz on the Bullboards: Investment Opportunities on the Rise

(Image via Datametrex AI Ltd.) A busy week for the markets means a busy week for the Stockhouse Bullboards. From sudden investment opportunities to new sector mainstays, we saw a little bit of everything over the last seven days. First up, here&CloseCurlyQuo...
Stockhouse.com | April 20, 2022 |

Shaping the Future of Medicine by Delivering Regenerative Medicines

(Click image to play video) Envision a chest pain that feels like the most severe form of heartburn you ever experienced before. This is one of the main symptoms of ischemia – a disease which millions of people around the globe live with every day. Treati...
Dave Jackson | December 8, 2020 |

Trillion Energy (CSE:TCF) reports further production growth

Trillion (TCF) has unveiled flow test results for the Guluc-2 natural gas well at the SASB gas field offshore Turkey Flow rates peaked at 16.35 MMcf/day with an initial production rate of about 6 MMcf/day Results stem from only 6 of 73 m of gas pay ...
Trevor Abes | March 29, 2023 |

Unlocking potential in TAG Oil’s Badr Oilfield Abu-Roash 'F' project

By TAG Oil Ltd. TAG Oil Ltd. (TSXV:TAO; OTCQX:TAOIF; FSE:T0P) , a Canadian-listed international oil and gas company, identifies significant untapped potential in the BED-1 field in the Western Desert of Egypt. Geological data highlights vast opportunities within th...
Research | September 19, 2024 |

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. Clinical-stage biopharmaceutical company Fate Thera...
Streetwise Reports | April 7, 2020 |
1 2 3 4 5